Cambia and Lorazepam drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Cambia (diclofenac potassium) and Lorazepam (lorazepam). Common drug interactions include thrombosis among females and diabetes mellitus among males.

The phase IV clinical study analyzes what interactions people have when they take Cambia and Lorazepam. It is created by eHealthMe based on reports of 46 people who take the same drugs from the FDA, and is updated regularly.

What is Cambia?

Cambia has active ingredients of diclofenac potassium. eHealthMe is studying from 2,339 Cambia users. Check the latest studies of Cambia.

What is Lorazepam?

Lorazepam has active ingredients of lorazepam. It is often used in stress and anxiety. eHealthMe is studying from 165,639 Lorazepam users. Check the latest studies of Lorazepam.



On Jul, 17, 2026

46 people who take Cambia and Lorazepam together, and have interactions are studied.

Cambia and Lorazepam drug interactions.

What are the common drug interactions of Cambia and Lorazepam, by gender? *:

female:

  1. Thrombosis (formation of a blood clot inside a blood vessel)
  2. Pneumonia
  3. Asthma
  4. Breakthrough pain
  5. Burning sensation
  6. Pain in extremity
  7. Weight decreased
  8. Abdominal discomfort
  9. Asthenia (weakness)
  10. Chronic kidney disease

male:

  1. Diabetes mellitus (diabetes, caused by a deficiency of the pancreatic hormone insulin)
  2. Hernia (hernia happens when part of an internal organ or tissue bulges through a weak area of muscle)
  3. Mental disorder (a psychological term for a mental or behavioural pattern or anomaly that causes distress or disability)
  4. Erythema nodosum (skin inflammation that results in reddish, painful, tender lumps most commonly located in the front of the legs below)
  5. Pyoderma gangrenosum (ulcerating condition of skin that results in heaped borders with a typical appearance)
  6. Pyrexia (fever)
  7. Vomiting
  8. Malaise (a feeling of general discomfort or uneasiness)
  9. Nasopharyngitis (inflammation of the nasopharynx)
  10. Productive cough

What are the common drug interactions of Cambia and Lorazepam, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

  1. Abdominal discomfort
  2. Decreased appetite
  3. Emotional disorder
  4. Nausea (feeling of having an urge to vomit)
  5. Paranoia (psychotic disorder characterized by delusions of persecution with or without grandeur)
  6. Rash
  7. Skin disorder (skin disease)
  8. Sleep-related eating disorder (abnormal eating patterns during the night)

40-49:

n/a

50-59:

  1. Hernia (hernia happens when part of an internal organ or tissue bulges through a weak area of muscle)
  2. Nasopharyngitis (inflammation of the nasopharynx)
  3. Productive cough
  4. Sepsis (a severe blood infection that can lead to organ failure and death)
  5. Sputum discoloured
  6. Decreased immune responsiveness
  7. Immune system disorder
  8. Arthralgia (joint pain)
  9. Mental disorder (a psychological term for a mental or behavioural pattern or anomaly that causes distress or disability)
  10. Erythema nodosum (skin inflammation that results in reddish, painful, tender lumps most commonly located in the front of the legs below)

60+:

  1. Breakthrough pain
  2. Burning sensation
  3. Pain in extremity
  4. Weight decreased
  5. Drug ineffective
  6. Nasopharyngitis (inflammation of the nasopharynx)
  7. Overdose
  8. Withdrawal syndrome (a discontinuation syndrome is a set of symptoms occurred due to discontinuation of substance)

What are the existing conditions these people have? *

  1. Crohn's Disease (a condition that causes inflammation of the gastrointestinal tract): 17 people, 36.96%
  2. Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 10 people, 21.74%
  3. Migraine (headache): 7 people, 15.22%
  4. Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 6 people, 13.04%
  5. Sleep Disorder: 5 people, 10.87%
  6. Pain: 5 people, 10.87%
  7. Post Herpetic Neuralgia (neuralgia caused by the varicella zoster virus): 4 people, 8.70%
  8. Hyperlipidaemia (presence of excess lipids in the blood): 4 people, 8.70%
  9. Headache (pain in head): 4 people, 8.70%
  10. Wheezing (a high-pitched whistling sound made while you breath): 3 people, 6.52%

* Approximation only. Some reports may have incomplete information.

Do you take Cambia and Lorazepam?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Cambia and Lorazepam:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Cambia:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Lorazepam:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Cambia and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Lorazepam and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on diclofenac potassium and lorazepam (the active ingredients of Cambia and Lorazepam, respectively), and Cambia and Lorazepam (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: